Biopolymer-Based Nanotechnology for Cancer Treatment explores various current and promising applications of polymeric nanoparticles as a tool for cancer treatment. This book provides introductory information on cancer biology and how biopolymers interact with tumor cells, covering the engineering aspects of drug delivery systems, immunological responses, and clinical implications. Following this introduction, the book explores a wide range of polymeric nanoparticles, analyzing their properties, synthesis methods, mechanisms of cancer targeting, and potential applications. Each chapter includes illustrative examples that highlight core concepts and practical applications of the material discussed, and it also reviews current challenges and future research directions. This book is a valuable resource for academic and industrial researchers, nanotechnologists, and materials scientists interested in innovative materials for cancer treatment.
1. Recent developments, current problems, and potential future applications of nanomedicine for anticancer drug combination therapies
2. The use of lipid nanoparticles in oral chemotherapy: biopharmaceutical barriers
3. Nucleic acid production, characterization, and formulation in lipid-polymer hybrid nanoparticles for cancer treatment
4. Metallic nanoparticles in drug delivery and cancer treatmentSilver nanoparticles in cancer therapy
5. Nanotechnology in cancer therapy: attacking the disease at its mechanistic roots
6. Effective and selective delivery of anticancer medicines by chitosan nanoparticles
7. Cancer treatment with nanoparticle-based medication delivery systems
8. Silver nanoparticles in cancer therapy
9. Nanopreparations for skin cancer therapy
10. Nanomedicines based on proteins as a vehicle for cancer drugs
11. Nanomedicines for the treatment of cancer: surface decoration techniques
12. Nanotoxicology profiling of cancer nanomedicines
Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK.
He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commissions innovation Radar Grand Prix of the Innovation Radar Prize 2020 for developing ground-breaking technology for breast cancer theranostics. Arun Kumar Singh has completed M. Pharm (Pharmaceutics) from Galgotias University, Greater Noida, India. Mr. Singh joined as an Assistant Professor in Amity Institute of Pharmacy, Amity University, Greater Noida. His area of interest is in the area of Nano-formulation, Blockchain, IoT, Machine learning, Cancer, Artificial intelligence, Big data and Neuroscience. He has authored one book with IOP publishing. He has published 5 chapters in the field of big data with prestigious River Publisher, Denmark. He has also published 24 review papers among which two are in Biochimica et Biophysica Acta (BBA) Reviews on Cancer. His cumulative impact factor is 85.6. He has published 28 books with publishers such as Springer, IOP, Elsevier, CRC PRESS and Wiley. His strengths are research skills, thinking innovation, leadership qualities, decision-making, and positive thinking. His hard-working nature and devotion to his work make him distinguishable and extraordinary.
